Interferon_NN
augments_VBZ
PML_NN
and_CC
PML\/RAR_NN
alpha_NN
expression_NN
in_IN
normal_JJ
myeloid_JJ
and_CC
acute_JJ
promyelocytic_JJ
cells_NNS
and_CC
cooperates_VBZ
with_IN
all-trans_JJ
retinoic_JJ
acid_NN
to_TO
induce_VB
maturation_NN
of_IN
a_DT
retinoid-resistant_JJ
promyelocytic_JJ
cell_NN
line_NN
._.

The_DT
PML_NN
gene_NN
is_VBZ
fused_VBN
to_TO
the_DT
retinoic_JJ
acid_NN
receptor_NN
alpha_NN
gene_NN
-LRB-_-LRB-
RAR_NN
alpha_NN
-RRB-_-RRB-
in_IN
the_DT
acute_JJ
promyelocytic_JJ
leukemia_NN
-LRB-_-LRB-
APL_NN
-RRB-_-RRB-
15_CD
;_:
17_CD
translocation_NN
._.

PML_NN
is_VBZ
expressed_VBN
in_IN
diverse_JJ
tissues_NNS
and_CC
cell_NN
lines_NNS
and_CC
localized_JJ
in_IN
the_DT
nucleus_NN
with_IN
a_DT
typical_JJ
speckled_JJ
pattern_NN
._.

In_IN
the_DT
bone_NN
marrow_NN
,_,
it_PRP
is_VBZ
preferentially_RB
expressed_VBN
in_IN
myeloid_JJ
cells_NNS
._.

PML_NN
appears_VBZ
to_TO
be_VB
transcriptionally_RB
regulated_VBN
by_IN
class_NN
I_NN
and_CC
II_CD
interferons_NNS
,_,
which_WDT
raises_VBZ
the_DT
possibility_NN
that_IN
interferons_NNS
modulate_VBP
the_DT
function_NN
and_CC
growth_NN
and_CC
differentiation_NN
potential_NN
of_IN
normal_JJ
myeloid_JJ
cells_NNS
and_CC
precursors_NNS
by_IN
activating_VBG
PML-dependent_JJ
pathways_NNS
._.

Similarly_RB
,_,
interferons_NNS
could_MD
act_VB
on_IN
APL_NN
cells_NNS
,_,
alone_RB
or_CC
in_IN
combination_NN
with_IN
all-trans_JJ
retinoic_JJ
acid_NN
-LRB-_-LRB-
RA_NN
-RRB-_-RRB-
,_,
especially_RB
if_IN
the_DT
PML\/RAR_NN
alpha_NN
fusion_NN
transcript_NN
that_WDT
results_VBZ
from_IN
the_DT
t_NN
-LRB-_-LRB-
15_CD
;_:
17_CD
-RRB-_-RRB-
is_VBZ
induced_VBN
by_IN
interferon_NN
._.

We_PRP
report_VBP
here_RB
that_IN
PML_NN
is_VBZ
expressed_VBN
at_IN
low_JJ
levels_NNS
or_CC
not_RB
expressed_VBN
in_IN
normal_JJ
circulating_VBG
human_JJ
monocytes_NNS
,_,
lymphocytes_NNS
,_,
and_CC
polymorphonucleate_JJ
cells_NNS
,_,
but_CC
is_VBZ
markedly_RB
induced_VBN
by_IN
interferon_NN
;_:
that_IN
PML_NN
and_CC
PML\/RAR_NN
alpha_NN
expression_NN
is_VBZ
augmented_VBN
by_IN
interferon_NN
in_IN
the_DT
NB4_NN
APL_NN
cell_NN
line_NN
,_,
which_WDT
carries_VBZ
the_DT
t_NN
-LRB-_-LRB-
15_CD
;_:
17_CD
-RRB-_-RRB-
,_,
and_CC
in_IN
APL_NN
blasts_NNS
from_IN
patients_NNS
;_:
that_IN
interferon_NN
inhibits_VBZ
growth_NN
and_CC
survival_NN
of_IN
NB4_NN
APL_NN
cells_NNS
in_IN
cooperation_NN
with_IN
RA_NN
;_:
that_IN
interferons_NNS
alone_RB
have_VBP
minimal_JJ
maturation_NN
effect_NN
on_IN
NB4_NN
cells_NNS
;_:
and_CC
,_,
finally_RB
,_,
that_IN
interferon_NN
gamma_NN
,_,
but_CC
not_RB
alpha_NN
or_CC
beta_NN
,_,
induces_VBZ
maturation_NN
and_CC
growth_NN
suppression_NN
of_IN
NB4_NN
cells_NNS
with_IN
de_FW
novo_FW
retinoid_NN
resistance_NN
,_,
and_CC
partially_RB
restores_VBZ
RA_NN
response_NN
._.

